CODX · Co-Diagnostics, Inc. · Executive Compensation
$1.07
+0.00 (+0.00%)
At close · Sep 30
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because certain elements of management's plans to mitigate the conditions that raised substantial doubt about the Company's ability to continue as a going concern are outside of the Company's control, including the ability to raise capital through equity or other financings, those elements cannot be considered probable according to ASC 205-40, and therefore cannot be considered in the evaluation of mitigating factors. As a result, management has concluded that substantial doubt exists about the Company's ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$6.82M
Shares
6.25M
Volume · Sep 30
87.38K
Avg daily vol (3M)
425.08K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Dwight H Egan | Chief Executive Officer | $1,261,300 |
| Brian Brown | Chief Financial Officer and Secretary | $1,040,473 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Dwight H Egan | Chief Executive Officer | $1,967,141 |
| Brian Brown | Chief Financial Officer and Secretary | $1,577,772 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Dwight H Egan | President & Chief Executive Officer | $2,224,002 |
| Brian Brown | Chief Financial Officer and Secretary | $2,153,138 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Daniel Bohrer | Executive Vice President of Finance and Accounting | Appointed | 2026-09-04 |
| Richard Abbott | President | Appointed | 2024-03-15 |